Daytime Sleepiness in Obesity: Mechanisms Beyond Obstructive Sleep Apnea-A Review

被引:127
作者
Panossian, Lori A. [1 ]
Veasey, Sigrid C.
机构
[1] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA
关键词
Obstructive sleep apnea; obesity; hypersomnolence; neurons/metabolism; sleep/physiology; MELANIN-CONCENTRATING HORMONE; POLYCYSTIC-OVARY-SYNDROME; OREXIN GENE-EXPRESSION; EYE-MOVEMENT SLEEP; SLOW-WAVE SLEEP; BARIATRIC SURGERY; ENERGY-BALANCE; GHRELIN LEVELS; RISK-FACTORS; INSULIN-RESISTANCE;
D O I
10.5665/sleep.1812
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Increasing numbers of overweight children and adults are presenting to sleep medicine clinics for evaluation and treatment of sleepiness. Sleepiness negatively affects quality of life, mental health, productivity, and safety. Thus, it is essential to comprehensively address all potential causes of sleepiness. While many obese individuals presenting with hypersomnolence will be diagnosed with obstructive sleep apnea and their sleepiness will improve with effective therapy for sleep apnea, a significant proportion of patients will continue to have hypersomnolence. Clinical studies demonstrate that obesity without sleep apnea is also associated with a higher prevalence of hypersomnolence and that bariatric surgery can markedly improve hypersomnolence before resolution of obstructive sleep apnea. High fat diet in both humans and animals is associated with hypersomnolence. This review critically examines the relationships between sleepiness, feeding, obesity, and sleep apnea and then discusses the hormonal, metabolic, and inflammatory mechanisms potentially contributing to hypersomnolence in obesity, independent of sleep apnea and other established causes of excessive daytime sleepiness.
引用
收藏
页码:605 / 615
页数:11
相关论文
共 141 条
[1]   Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat [J].
Akanmu, MA ;
Ukponmwan, OE ;
Katayama, Y ;
Honda, K .
NEUROSCIENCE RESEARCH, 2006, 54 (03) :165-170
[2]   Sympathetic neural activation in visceral obesity [J].
Alvarez, GE ;
Beske, SD ;
Ballard, TP ;
Davy, KP .
CIRCULATION, 2002, 106 (20) :2533-2536
[3]  
[Anonymous], SLEEP BREATH
[4]  
[Anonymous], EUR RESP J
[5]   The Effect of CPAP in Normalizing Daytime Sleepiness, Quality of Life, and Neurocognitive Function in Patients with Moderate to Severe OSA [J].
Antic, Nick A. ;
Catcheside, Peter ;
Buchan, Catherine ;
Hensley, Michael ;
Naughton, Matthew T. ;
Rowland, Sharn ;
Williamson, Bernadette ;
Windler, Samantha ;
McEvoy, R. Doug .
SLEEP, 2011, 34 (01) :111-119
[6]   CSF versus serum leptin in narcolepsy: Is there an effect of hypocretin deficiency? [J].
Arnulf, Isabelle ;
Lin, Ling ;
Zhang, Jing ;
Russell, I. Jon ;
Ripley, Beth ;
Einen, Mali ;
Nevsimalova, Sonia ;
Bassetti, Claudio ;
Bourgin, Patrice ;
Nishino, Seiji ;
Mignot, Emmanuel .
SLEEP, 2006, 29 (08) :1017-1024
[7]   Insulin resistance and daytime sleepiness in patients with sleep apnoea [J].
Barcelo, A. ;
Barbe, F. ;
de la Pena, M. ;
Martinez, P. ;
Soriano, J. B. ;
Pierola, J. ;
Agusti, A. G. N. .
THORAX, 2008, 63 (11) :946-950
[8]  
Basta M, 2008, J CLIN SLEEP MED, V4, P19
[9]   Wheel running in female C57BL/6J mice: impact of oestrus and dietary fat and effects on sleep and body mass [J].
Basterfield, L. ;
Lumley, L. K. ;
Mathers, J. C. .
INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 (02) :212-218
[10]   Excessive daytime sleepiness in a general population sample: The role of sleep apnea, age, obesity, diabetes, and depression [J].
Bixler, EO ;
Vgontzas, AN ;
Lin, HM ;
Calhoun, SL ;
Vela-Bueno, AV ;
Kales, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08) :4510-4515